NCT05359848 2026-02-20
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
State University of New York at Buffalo
Phase NA Recruiting
Clinical Trials
9 trialsNCT06097533 2024-10-26
BELCANTO
University Hospital Schleswig-Holstein
Phase 2 Recruiting
NCT04931329 2021-11-10
THERANOVA-LIM
University Hospital, Limoges
Unknown
NCT02824042 2020-07-31
Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
Bayer
Phase 1 Completed
NCT02368951 2017-07-12
Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
Bayer
Phase 1 Terminated
NCT02645357 2017-02-09
ONCO-CODES
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase NA Completed
NCT02906423 2017-01-11
Results From a Health System-wide Implementation of a Quality of Life Questionnaire
Allina Health System
Completed
NCT02357953 2016-06-09
ThermoD-PAC
Gustave Roussy, Cancer Campus, Grand Paris
Completed
NCT02457351 2016-05-23
Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study
Bayer
Phase 1 Completed